Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03307070 · ClinicalTrials.gov registry record · NA
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT03307070: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03307070 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03307070, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
Cognitive behavioral therapy for major depressive disorder (MDD) was adapted for individuals with moderate to severe traumatic brain injury (TBI) (CBT-TBI). A structured, treatment manual was developed. The primary aim is to evaluate the acceptability and tolerability of, and adherence to, CBT-TBI in a randomized waitlist-controlled, 12-week pilot trial (N=40). The exploratory aim is to evaluate the potential efficacy of CBT-TBI for MDD in the randomized pilot trial (N=40) and possible moderators and mediators of outcome.
Interventions
- OTHER Waitlist Control
- BEHAVIORAL Cognitive Behavioral Therapy for individuals with TBI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2017-09-23 |
| Est. Completion | 2022-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03307070
The ClinicalTrials.gov registry entry for NCT03307070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Waitlist Control is the first listed.
NCT03307070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03307070 about?
NCT03307070 is a clinical study titled "Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury". Cognitive behavioral therapy for major depressive disorder (MDD) was adapted for individuals with moderate to severe traumatic brain injury (TBI) (CBT-TBI). A structured, treatment manual was developed. The primary aim is to evaluate the acceptability and tolerability of, and adherence to, CBT-TBI ...
What is the current status of trial NCT03307070?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2017-09-23. Estimated completion is 2022-11-28.
What interventions are being tested in trial NCT03307070?
The interventions under investigation include: Waitlist Control (OTHER), Cognitive Behavioral Therapy for individuals with TBI (BEHAVIORAL).
Who is sponsoring clinical trial NCT03307070?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.